Form 4: Zura Bio Director Acquires Stock Options

Zura Bio Ltd. Director Ajay Nirula was granted 37,812 stock options with an exercise price of $6.53, vesting over one year starting February 21, 2026.

Summary

• Ajay Nirula, a Director of Zura Bio Ltd. (ZURA), acquired 37,812 derivative securities in the form of Share Options (Right to Buy).
• The transaction date for the grant was February 21, 2026.
• The exercise price for these options is $6.53 per share.
• The options will vest in twelve substantially equal monthly installments over a one-year period, commencing February 21, 2026.
• Any remaining unvested portion will vest the day before the next annual meeting of shareholders following the grant date, subject to continued service.
• The expiration date for these options is February 21, 2036.
• Following this transaction, Ajay Nirula beneficially owns 37,812 derivative securities directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating continued alignment of a key director's interests with shareholder value through equity participation and a commitment to long-term service.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term performance.
• The vesting schedule over one year, contingent on continued service, indicates a commitment from the director to the company's future.

Future Outlook

The option award's vesting schedule extends over a one-year period, contingent on the director's continued service, indicating an expectation of ongoing commitment and alignment with the company's long-term objectives.

Industry Context

StockSavvy.ai notes that the grant of stock options to directors is a standard practice in the biotechnology and pharmaceutical industries, serving as a key component of executive and board compensation packages to align leadership incentives with shareholder value creation.

Stakeholder Impact

• Shareholders: The grant of options to a director can enhance alignment between management and shareholder interests, potentially leading to better long-term performance.
• Employees: The compensation structure for directors can influence overall compensation philosophy within the company.

Next Steps

• Ajay Nirula's continued service to Zura Bio Ltd. is required for the options to vest according to the established schedule.

Key Dates

Keywords

Zura Bio, ZURA, stock options, director compensation, insider transaction, Form 4, equity grant